Drug Information

Drug General Information
Drug ID
D08PWL
Former ID
DNC011230
Drug Name
N-n-propyl-7-methoxytacrine hydrochloride
Drug Type
Small molecular drug
Indication Discovery agent Investigative [531150]
Formula
C17H23ClN2O
Canonical SMILES
CCCNC1=C2CCCCC2=NC3=C1C=C(C=C3)OC.Cl
InChI
1S/C17H22N2O.ClH/c1-3-10-18-17-13-6-4-5-7-15(13)19-16-9-8-12(20-2)11-14(16)17;/h8-9,11H,3-7,10H2,1-2H3,(H,18,19);1H
InChIKey
NZCRVRLOUKICBC-UHFFFAOYSA-N
PubChem Compound ID
52945679
Target and Pathway
Target(s) Acetylcholinesterase Target Info Inhibitor [531150]
KEGG Pathway Glycerophospholipid metabolism
Cholinergic synapse
PANTHER Pathway Muscarinic acetylcholine receptor 1 and 3 signaling pathway
Muscarinic acetylcholine receptor 2 and 4 signaling pathway
Nicotinic acetylcholine receptor signaling pathway
Pathway Interaction Database ATF-2 transcription factor network
PathWhiz Pathway Phospholipid Biosynthesis
WikiPathways Monoamine Transport
Biogenic Amine Synthesis
Acetylcholine Synthesis
Integrated Pancreatic Cancer Pathway
References
Ref 531150Bioorg Med Chem Lett. 2010 Oct 15;20(20):6093-5. Epub 2010 Aug 16.Synthesis and in vitro evaluation of N-alkyl-7-methoxytacrine hydrochlorides as potential cholinesterase inhibitors in Alzheimer disease.
Ref 531150Bioorg Med Chem Lett. 2010 Oct 15;20(20):6093-5. Epub 2010 Aug 16.Synthesis and in vitro evaluation of N-alkyl-7-methoxytacrine hydrochlorides as potential cholinesterase inhibitors in Alzheimer disease.